MiR-27a modulates radiosensitivity of triple- negative breast cancer (TNBC) cells by targeting CDC27

Medical Science Monitor

Volumn 21, Issue , 2015, Pages 1297-1303

  Ren, Yong Qiang ^a   Fu, Fengkui ^b   Han, Jianjun ^c  

^a Yishui Central Hospital   (China)

^b BINZHOU PEOPLE S HOSPITAL   (China)

^c HEBEI UNIVERSITY OF ENGINEERING   (China)

Author keywords

Adjuvant; Anaphase promoting complex cyclosome; Apc3 subunit; MicroRNAs; Radiotherapy; Triple negative breast neoplasms

Indexed keywords

ANAPHASE PROMOTING COMPLEX SUBUNIT 3; CHOLECYSTOKININ OCTAPEPTIDE; MICRORNA; MICRORNA 27A; UNCLASSIFIED DRUG; CDC27 PROTEIN, HUMAN; HYBRID PROTEIN; MIRN27 MICRORNA, HUMAN; OLIGONUCLEOTIDE; SMALL INTERFERING RNA; TUMOR PROTEIN;

3' UNTRANSLATED REGION; ARTICLE; BREAST CANCER CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IONIZING RADIATION; IRRADIATION; LUCIFERASE ASSAY; MTT ASSAY; PROTEIN EXPRESSION; PROTEIN TARGETING; RADIOSENSITIVITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRIPLE NEGATIVE BREAST CANCER; WESTERN BLOTTING; ANTAGONISTS AND INHIBITORS; BINDING SITE; BIOSYNTHESIS; BREAST; CELL CULTURE; CONSERVED SEQUENCE; CYTOLOGY; DOWN REGULATION; DRUG EFFECTS; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GENETICS; HEK293 CELL LINE; METABOLISM; MOLECULARLY TARGETED THERAPY; PATHOLOGY; PHYSIOLOGY; RADIATION RESPONSE; RADIATION TOLERANCE; RNA INTERFERENCE; TRIPLE NEGATIVE BREAST NEOPLASMS; TUMOR CELL LINE; TUMOR STEM CELL ASSAY;

APC3 SUBUNIT, ANAPHASE-PROMOTING COMPLEX-CYCLOSOME; BINDING SITES; BREAST; CELL LINE, TUMOR; CELLS, CULTURED; CONSERVED SEQUENCE; DOWN-REGULATION; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HUMANS; MICRORNAS; MOLECULAR TARGETED THERAPY; NEOPLASM PROTEINS; OLIGONUCLEOTIDES; RADIATION TOLERANCE; RECOMBINANT FUSION PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRIPLE NEGATIVE BREAST NEOPLASMS; TUMOR STEM CELL ASSAY;

EID: 84928946856     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.893974     Document Type: Article

References (20)

1. Foulkes WD, Smith IE, Reis-Filho JS: Triple-negative breast cancer. N Engl J Med, 2010; 363: 1938–48
2. Gasparini P, Lovat F, Fassan M et al: Protective role of mir-155 in breast cancer through rad51 targeting impairs homologous recombination after irradiation. Proc Natl Acad Sci USA, 2014; 111: 4536–41
3. Bartel DP: Micrornas: Genomics, biogenesis, mechanism, and function. Cell, 2004; 116: 281–97
4. Yahya SM, Elsayed GH: A summary for molecular regulations of mirnas in breast cancer. Clin Biochem, 2015; 48(6): 388–96
5. Min W, Wang B, Li J et al: The expression and significance of five types of mirnas in breast cancer. Med Sci Monit Basic Res, 2014; 20: 97–104
6. Korner C, Keklikoglou I, Bender C et al: Microrna-31 sensitizes human breast cells to apoptosis by direct targeting of protein kinase c epsilon (pkcepsilon). J Biol Chem, 2013; 288: 8750–61
7. Gasparini P, Cascione L, Fassan M et al: Microrna expression profiling identifies a four microrna signature as a novel diagnostic and prognostic biomarker in triple negative breast cancers. Oncotarget, 2014; 5: 1174–84
8. Tang W, Yu F, Yao H et al: Mir-27a regulates endothelial differentiation of breast cancer stem like cells. Oncogene, 2014; 33: 2629–38
9. Mertens-Talcott SU, Chintharlapalli S, Li X, Safe S: The oncogenic microrna- 27a targets genes that regulate specificity protein transcription factors and the g2-m checkpoint in mda-mb-231 breast cancer cells. Cancer Res, 2007; 67: 11001–11
10. Thornton BR, Ng TM, Matyskiela ME et al: An architectural map of the anaphase- promoting complex. Genes Dev, 2006; 20: 449–60
11. Talvinen K, Karra H, Pitkanen R et al: Low cdc27 and high securin expression predict short survival for breast cancer patients. APMIS, 2013; 121: 945–53
12. Singh N, Wiltshire TD, Thompson JR et al: Molecular basis for the association of microcephalin (mcph1) protein with the cell division cycle protein 27 (cdc27) subunit of the anaphase-promoting complex. J Biol Chem, 2012; 287: 2854–62
13. Stevens KN, Wang X, Fredericksen Z et al: Evaluation of associations between common variation in mitotic regulatory pathways and risk of overall and high grade breast cancer. Breast Cancer Res Treat, 2011; 129: 617–22
14. Tang W, Zhu J, Su S et al: Mir-27 as a prognostic marker for breast cancer progression and patient survival. PloS One, 2012; 7: e51702
15. Guttilla IK, White BA: Coordinate regulation of foxo1 by mir-27a, mir-96, and mir-182 in breast cancer cells. J Biol Chem, 2009; 284: 23204–16
16. Chang L, Zhang Z, Yang J et al: Molecular architecture and mechanism of the anaphase-promoting complex. Nature, 2014; 513: 388–93
17. Lee SJ, Langhans SA: Anaphase-promoting complex/cyclosome protein cdc27 is a target for curcumin-induced cell cycle arrest and apoptosis. BMC Cancer, 2012; 12: 44
18. Ha G, Roth A, Lai D et al: Integrative analysis of genome-wide loss of heterozygosity and monoallelic expression at nucleotide resolution reveals disrupted pathways in triple-negative breast cancer. Genome Res, 2012; 22: 1995–2007
19. Yang L, Perez AA, Fujie S et al: Wnt modulates mcl1 to control cell survival in triple negative breast cancer. BMC Cancer, 2014; 14: 124
20. Rajkumar T, Gopal G, Selvaluxmi G, Rajalekshmy KR: Cdc27 protein is involved in radiation response in squamous cell cervix carcinoma. Indian J Biochem Biophys, 2005; 42: 271–78